CClinicalTrials.gg
RecruitingNCT05497115Updated Sep 9, 2026

Testing a Scalable Model of Care to Improve Patients Access to Mental Health Services After Traumatic Injury

An interventional study of Trauma Resilience and Recovery Program in Posttraumatic Stress Disorder and Depression, sponsored by Medical University of South Carolina. Recruiting at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study to learn about patients' experience with the Trauma Resilience and Recovery program (TRRP) and/or the enhanced care group.

Read the detailed description

In 2015, our team launched the Trauma Resilience and Recovery Program (TRRP) at the Medical University of South Carolina's Level I trauma center. TRRP is a stepped model of care that is designed to deliver education at the bedside about mental health recovery after traumatic injury as well as risk assessment and brief intervention for high-risk patients (Step 1), foster symptom self-monitoring and continued education via our automated text messaging system (Step 2), screen for PTSD and depression by chatbot or telephone 30 days post-injury (Step 3), and provide a referral and warm handoff to mental health services if needed (Step 4). The purpose of the proposed study is to examine the clinical and functional impact of TRRP over a period of 12 months. We will conduct a randomized controlled trial (RCT) with one-year follow up of TRRP vs. enhanced usual care (EUC) with 350 patients at The George Washington University (GWU) hospital, which serves a diverse population of \~2000 trauma center patients per year (15% penetrating mechanism). Trained, supervised interviewers blind to study condition will assess clinical and functional outcomes 3-, 6-, and 12-months post-baseline (Aim 1). Qualitative interviews will be conducted with ≥ 30 patients from underrepresented minority groups (i.e., African American, Latinx) as well as ≥ 20 victims of violent trauma (penetrating mechanism) to identify opportunities to strengthen the model to meet the diverse needs of these patients (Aim 2). GWU does not currently have an embedded mental health program in place, which will enable us to explore implementation determinants systematically (Aim 3).

02

Conditions studied

  • Posttraumatic Stress Disorder
  • Depression
03

In context

Stress Disorders, Post-Traumatic

2,239 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 554 are open to participants now.

This study's planned enrollment of 350 is above the median of 70 across 1,858 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • English- or Spanish-speaking patients ≥ 16 years old who are admitted to George Washington University hospital's trauma center and screen positive on the Injured Trauma Survivors Screen (which indicates risk for development of posttraumatic stress disorder and/or depression) will be included.

Exclusion criteria

Exclusion Criteria:

  • Patients who have a Glasgow Coma Scale score under 13 at hospital admission, moderate to severe cognitive impairment (as measured by the Montreal Cognitive Assessment), active psychosis, or injury that prevents verbal communication (e.g., serious head or spinal cord injury) or is self-inflicted will be excluded. Patients with positive substance use screens via GWU's SBIRT protocol (\~7% of the patient population) will be assessed by the clinical team with reference to severity and recency of substance use problems. We have found at MUSC that a high percentage of patients with SBIRT- positive screens are nevertheless good candidates for TRRP (>85%), but patients with serious, active substance abuse problems are likely not good candidates for TRRP and therefore will be excluded and referred to a substance use treatment center.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    Trauma Resilience and Recovery Program

    TRRP is a stepped model of care that delivers education at the bedside about mental health recovery after traumatic injury as well as risk assessment and brief intervention for high-risk patients (Step 1), fosters symptom monitoring and continued education (Step 2), screens for PTSD and depression 30 days post-injury (Step 3), and provides a referral and warm handoff to mental health services if needed (Step 4)

    Behavioral: Trauma Resilience and Recovery Program

  • No intervention
    Enhanced Usual Care Condition

    Patients in the EUC arm will be given education about mental health after traumatic injury, educational materials about mental health recovery, and local referral information to assist treatment-seeking patients in seeking care.

Interventions

  • BehavioralTrauma Resilience and Recovery Program

    The Trauma Resilience and Recovery Program is a stepped model of care that is designed to deliver education at the bedside about mental health recovery after traumatic injury as well as risk assessment and brief intervention for high-risk patients (Step 1), foster symptom self-monitoring and continued education (Step 2), screen for PTSD and depression 30 days post-injury (Step 3), and provide a referral and warm handoff to mental health services if needed (Step 4).

06

What researchers measure

Primary outcomes

  1. Change from Baseline PTSD Checklist for DSM-5 8- item (PCL8-5) at 3-,6-, and 12-month

    The PTSD Checklist for DSM-5 (Weathers et al., 2013) is a self-report measure that assesses the extent to which participants are bothered by the DSM-5 PTSD symptoms. Each symptom is rated on a scale of 0 (not at all) to 4 (extremely). Total scores are obtained by summing the scores of all items. The 8-item adaptation includes assessment of intrusive thoughts, avoidance of external reminders, negative expectations of self/ world, easily startled, emotional cue reactivity, avoidance of thoughts/emotions, loss of interest, and difficulty concentrating. The PCL8-5 has strong psychometric properties and clinical utility data similar to that of the long version.

    Time frame: Baseline, 3-, 6-, and 12- months post-baseline

Secondary outcomes

  1. Demographics

    Patients will provide standard demographic information, such as race/ethnicity; sex; gender identity; immigration, insurance, marital, and socioeconomic status; language; educational attainment; and occupation

    Time frame: Baseline

  2. Injured Trauma Survivor Screen (ITSS)

    Injured Trauma Survivor Screen (ITSS) is a 9-item measure used to assess risk for development of posttraumatic stress symptoms following injury. Items are rated yes=1 and no=0. If the sum of questions 1, 2, 3, 5, and 6 is equal to or greater than 2, the screen is positive for PTSD risk. If the sum of questions 3, 4, 7, 8, and 9 is equal or greater than 2, the screen is positive for depression risk.

    Time frame: Baseline

  3. Electronic Medical Record Data (EMR)

    Data will be collected at baseline via the electronic medical record including patients' length of stay; injury severity scores; number of emergency department visits; and opioid, anti-anxiety and anti-depression medications prescribed.

    Time frame: Baseline

  4. The Kessler 6 (K6)

    The Kessler 6 (K6) is a screening scale for nonspecific distress to discriminate cases of severe mental illness. Items are rated on a 5-point Likert scale (0-4). Total scores range from 0-24 and are calculated as the sum of all item ratings, with a total score ≥ 5 indicating moderate levels of distress and scores ≥ 13 indicating severe mental illness. This measure has been shown to have strong psychometric properties.

    Time frame: Baseline, 3-, 6-, and 12- months post-baseline

  5. Patient Health Questionnaire-9 (PHQ-9)

    The Patient Health Questionniare-9 (PHQ-9) assesses the presence and frequency of 9 core depressive symptoms. Items are rated on a 4-point Likert scale (0-3). Total scores range from 0-27 and are calculated as the sum of all item ratings, with a total score of ≥ 10 indicating clinical significance.

    Time frame: 3-, 6-, and 12-months post- baseline assessment

  6. PROMIS Emotional and Instrumental Support

    The PROMIS Emotion and Instrumental Support measure assesses perceived feelings of being cared for and valued as a person; having confidant relationships and availability of assistance with material, cognitive, or task performance. * Calculate a summed score across all items. All item responses scored on a scale of 1-5 where Never = 1, Always = 5 * 3\. Score of a 50 is the average for US population, SD of 10

    Time frame: Baseline, 3-, 6-, and 12- months post-baseline

  7. PROMIS Self-Efficacy

    The 8-item PROMIS Self-Efficacy scale is a measure of confidence in one's ability to deal effectively with a variety of stressful situations. * Calculate a summed score access all items. All item responses scored on a scale of 1-5 where Never=1, Always = 5 * Score of a 50 is the average for US population, SD of 10.

    Time frame: 3-, 6-, and 12-months post- baseline assessment

  8. PROMIS Global Health

    The 10-item PROMIS Global Health questionnaire measures one's overall evaluation of one's physical and mental health.

    Time frame: 3, 6, and 12-months post- baseline assessment

  9. PROMIS Pain Intensity and Interference Scale

    The PROMIS Pain Intensity and Interference scale assesses patients' pain and the extent to which it affects enjoyment of various activities in the past 7 days. * Calculate a summed score access all items. All item responses scored on a scale of 1-5 where Never=1, Always = 5 * Score of a 50 is the average for US population, SD of 10.

    Time frame: 3-, 6-, and 12-months post- baseline assessment

  10. PROMIS Sleep Disturbance

    The 4-item PROMIS Sleep Disturbance scale assesses perceptions of sleep quality, sleep depth, and restoration associated with sleep. * Calculate a summed score access all items. All item responses scored on a scale of 1-5. * Score of a 50 is the average for US population, SD of 10.

    Time frame: 3, 6, and 12-months post- baseline assessment

  11. National Health Interview Survey Barriers to Care

    This protocol includes 5 interviewer-administered questions from the National Health Interview Survey (NHIS) Barriers to Care designed to assess when medical care was last sought, usual place of care, frequency of getting medical care and reasons for not getting medical care.

    Time frame: Baseline, 3-, 6-, and 12- months post-baseline

  12. National Health Interview Survey Healthcare Utilization

    This protocol includes interviewer-administered questions from the National Health Interview Survey (NHIS) Healthcare Utilization designed to assess when medical care was last sought, usual place of care, frequency of getting medical care and reasons for not getting medical care.

    Time frame: Baseline and 12- months post-baseline

  13. NHIS Mental Health Care Module

    6 items is designed to assess when mental health care was last sough, usual place of care, frequency of getting mental health care and reasons for not getting mental health care.

    Time frame: Baseline, 3-,6-, and 12-month post baseline

  14. NHIS Job Status

    Consistent with Zatzick and colleagues (2008) we will ask patients about post-injury occupational status.

    Time frame: Baseline, 3-,6-,and 12-month post baseline

  15. CMH SDOH items

    The Centers for Medicare \& Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (CMMI) made the Accountable Health Communities (AHC) Health-Related Social Needs (HRSN) Screening Tool to use in the AHC Model.1 The test is to see if systematically finding and dealing with the health-related social needs of Medicare and Medicaid beneficiaries has any effect on their total health care costs and makes their health outcomes better. The Tool can help providers find out patients' needs in these 5 core domains that community services can help with: Housing instability, food insecurity, transportation problems, Utility help needs and interpersonal safety.

    Time frame: Baseline, 3-,6-,12-month post baseline

  16. The California Health Interview Survey (CHIS) question

    The California Health Interview Survey (CHIS) question allows a binary measurement of perceived prejudice, stereotyping, and discrimination in clinical encounters and experience.

    Time frame: Baseline, 3-, 6-, and 12- months post-baseline

  17. Stigma Scale for Receiving Psychological Help

    The Stigma Scale for Receiving Psychological Help assesses individuals' perceptions of how stigmatizing it is to receive psychological treatment. The SSRPH consists of 5 questions rated on a 4-point Likert scale. Total Score Instructions: Total score of the 5 items. No Items are reverse scored.

    Time frame: 3-month post- baseline assessment

  18. Discrimination in Medical Settings

    The 7-item Discrimination in Medical Settings will measure perceived discrimination.

    Time frame: 3-month post baseline

  19. Collective Efficacy (Neighborhood Environment)

    The Neighborhood Environment Scale measures perceived neighborhood context and provides an estimate of cumulative exposure to adversity in childhood.

    Time frame: 3-months post-baseline

  20. National Adverse Childhood Experiences Questions

    The six-item standard measure from the U.S. Department of Agriculture Economic Research Service is a validated, well-established measure of the availability, accessibility, and affordability of nutritionally adequate food.

    Time frame: 3-months post-baseline

  21. NIDA Quick Screen (items 2-4); alcohol, tobacco, prescription and illicit drug use

    The NIDA Quick Screen is a validated instrument designed to assist providers in screening adults for substance use. The screen simply inquires whether a participant has used drugs (mood-altering, illegal, or prescription for nonmedical reasons), alcohol, or tobacco products within the past year and how often these substances have been used.

    Time frame: 3-, 6-, and 12-months post- baseline assessment

  22. AUDIT-C

    The Alcohol Use Disorders Identification Test (AUDIT-C) is an alcohol screen that can help identify patients who are hazardous drinkers or have active alcohol use disorders (including alcohol abuse or dependence).

    Time frame: 3-,6-,12-month post baseline

  23. Acceptance of Treatment Referral and Initiation of Treatment

    Patients will be asked whether they considered seeking assistance for mental health needs and whether they actually sought help. These questions will be based on semi-structured interviews administered via our needs assessment that were adapted from epidemiologic interviews conducted by our team in the aftermath of the September 11, 2001 terrorist attacks and recent natural disasters. Follow-up questions will inquire about whether patients sought help from family members, friends, chaplains, mental health professionals, or other health care professionals.

    Time frame: 3-, 6-, and 12-months post- baseline assessment

07

Study locations

1 of 1 sites recruiting
  • George Washington University Hospital
    Washington, Virginia 20037, United States
    • Susan Kartiko, MD/PhD · Contact · skartiko@mfa.gwu.edu · 2026776219
    • Susan Kartiko, MD/PhD · Sub investigator
    • Babak Sarani, MD · Sub investigator
    • Brandon A Kohrt, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • Espeleta HC, Witcraft SM, Raffa T, Kartiko S, Dawson D, Becerra G, Roisman H, Hughes-Halbert C, Mueller M, Powell E, Brock T, Sarani B, Ruggiero KJ. Hybrid 1 randomized controlled trial of an integrated stepped-care mental health intervention for traumatic injury patients. Contemp Clin Trials. 2024 Nov;146:107694. doi: 10.1016/j.cct.2024.107694. Epub 2024 Sep 17. PubMed 39299544 ↗

Study documents

  • Informed consent form · Mar 14, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — First, we will analyze the qualitative and quantitative data from our interviews and randomized controlled trial and will share these data via The National Database for Clinical Trials Related to Mental Illness. We will prepare both brief and comprehensive reports for AHRQ as we have done in prior NIH studies. We also will disseminate reports of our findings via print copy to the MUSC and GWU Public Relations office and websites. Additionally, we will prepare manuscripts for submission to research journals, such as JAMA, JAMA Surgery, JAMA Psychiatry, Am J Psychiatry, J Trauma and Acute Care Surgery, J Am College of Surgeons, Am J Public Health, and other sources that ensure broad dissemination. Additionally, as we have done previously with other federally funded grants, we will seek to present our findings to AHRQ staff and at national and international conferences.

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05497115
Lead sponsor
Medical University of South Carolina
Collaborators
George Washington University, Agency for Healthcare Research and Quality (AHRQ)
Responsible party
Kenneth Ruggiero (Principal Investigator, Medical University of South Carolina) — Principal investigator
First posted
Aug 11, 2022
Start date
Nov 4, 2022
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Gabriela Becerra, BS
Contact
becerra@musc.edu
8439982602
Hannah Espeleta, PhD
Contact
espeleta@musc.edu
84377957658
Kenneth Ruggiero, PhD
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion